高压氧治疗对炎症性和瘘管性储袋并发症有效
回肠储袋肛管吻合术(IPAA)是药物难治性溃疡性结肠炎的首选手术,储袋相关并发症(储袋炎、袖口炎或瘘管)发生率高达50%,近1/5患者对包括生物制剂在内的内科治疗无效。缺氧被认为是这些慢性难治性并发症的触发因素,治疗缺氧可能对该人群有治疗获益。本研究探讨高压氧治疗(HBOT)对药物难治性储袋相关并发症患者的有效性。
要点
- IPAA是药物难治性溃疡性结肠炎的首选手术,储袋相关并发症发生率高达50%。
- 近1/5患者出现对包括生物制剂在内的内科治疗无效的储袋相关并发症。
- 缺氧被认为是慢性难治性并发症的触发因素,治疗缺氧可能带来治疗获益。
核心结论
- 研究探讨高压氧治疗对药物难治性储袋相关并发症患者的有效性。
研究设计与样本
- 研究对象为药物难治性储袋相关并发症患者,干预为高压氧治疗(HBOT),评估其有效性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ileal pouch-anal anastomosis (IPAA) is the surgical treatment of choice for medically refractory ulcerative colitis. Pouch-related complications, such as pouchitis, cuffitis, or fistulae, occur in up to 50% of patients. Nearly 1 in 5 patients develop pouch-related complications refractory to medical therapy, including biologics. Hypoxia has been suggested as a trigger for these chronic refractory complications, and treating hypoxia may be of therapeutic benefit in this patient population. We investigated the effectiveness of hyperbaric oxygen therapy (HBOT) for patients with medically refractory pouch-related complications.
引用
- Fahad H, Dulai PS, Shen B, et al. Hyperbaric Oxygen Therapy Is Effective in the Treatment of Inflammatory and Fistulizing Pouch Complications. Clin Gastroenterol Hepatol. 2020. PMID: 32565291. doi:10.1016/j.cgh.2020.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。